33156-U
TMSI+ 吡啶，1：4（Sylon™ TP）
别名:
1-(三甲基硅基)咪唑 - 吡啶混合物, TMSI+吡啶, 甲硅烷基化混合物 VII
InChI
1S/C6H12N2Si.C5H5N/c1-9(2,3)8-5-4-7-6-8;1-2-4-6-5-3-1/h4-6H,1-3H3;1-5H
SMILES string
c1ccncc1.C[Si](C)(C)n2ccnc2
InChI key
PFVKFOIOKNIZKY-UHFFFAOYSA-N
packaging
pkg of 1 × 25 mL
concentration
(TMSI+Pyridine, 1:4)
Application
TMSI+PYRIDINE, 1:4 (Sylon™ TP) may be used as a derivatization reagent for the measurement of liver and plasma precursor sterols using gas chromatography coupled with mass spectrometry while investigating the dual-action glycogenolysis/cholesterolgenesis inhibitors that act through inhibition of both glycogen phosphorylase and CYP51.
Legal Information
Sylon is a trademark of Sigma-Aldrich Co. LLC
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2
存储类别
3 - Flammable liquids
wgk
WGK 3
flash_point_f
62.6 °F - closed cup
flash_point_c
17 °C - closed cup
法规信息
新产品
此项目有
Comparison between Solvent Extraction Using Gas Chromatography Mass Spectrometry Triple Quadrupole (GCMS-QQQ) of Cholesterol and Cholesterol Oxidation Derivatives
A.R. Alina
Middle-East Journal of Scientific Research 13, 13, 43-48 (2013)
H James Harwood et al.
Journal of lipid research, 46(3), 547-563 (2004-12-18)
Diabetic dyslipidemia requires simultaneous treatment with hypoglycemic agents and lipid-modulating drugs. We recently described glycogen phosphorylase inhibitors that reduce glycogenolysis in cells and lower plasma glucose in ob/ob mice (J. Med. Chem., 41: 2934, 1998). In evaluating the series prototype
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持